STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Benitec Biopharma to Participate in Upcoming Conferences in March

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Benitec Biopharma (NASDAQ: BNTC), a clinical-stage biotechnology company specializing in gene therapy and 'Silence and Replace' DNA-directed RNA interference (ddRNAi) platform, has announced its participation in three major healthcare conferences in March 2025.

The company will present at:

  • TD Cowen 45th Annual Health Care Conference on March 5, 2025 (9:50-10:20 AM EST)
  • Leerink Partners Global Healthcare Conference on March 12, 2025 (9:20-9:50 AM EST)
  • 2025 Muscular Dystrophy Association Clinical & Scientific Conference in Dallas, TX, featuring two sessions on March 18-19, 2025, focusing on Oculopharyngeal Muscular Dystrophy and Clinical Trial Updates

All presentations will be available via live webcast, and one-on-one meetings can be scheduled with management.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

HAYWARD, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference ("ddRNAi") platform, today announced that its management team will participate in the following upcoming conferences.

TD Cowen 45th Annual Health Care Conference
Date: March 5, 2025
Time of Presentation: 9:50 AM to 10:20 AM EST
Format: Presentation & 1x1 Meetings

The Benitec presentation will also be available via live webcast here.

Leerink Partners Global Healthcare Conference 2025
Date: March 12, 2025
Time of Presentation: 9:20 AM to 9:50 AM EST
Format: Fireside Chat & 1x1 Meetings

The Benitec presentation will also be available via live webcast here.

2025 Muscular Dystrophy Association Clinical & Scientific Conference
Session: Pre-clinical and Clinical Efforts in Oculopharyngeal Muscular Dystrophy
Date & Time of Panel Discussion: March 18th, 2025 from 11:00 AM to 12:00 PM CST
Location: Dallas, TX

Session: Clinical Trial Updates, Late-Breaking Oral Abstracts
Date & Time of Presentation: March 19th, 2025 from 1:15 PM to 1:30 PM CST
Location: Dallas, TX

Please contact your conference representative to schedule a 1x1 meeting with Benitec management.

About Benitec Biopharma Inc.
Benitec Biopharma Inc. (“Benitec” or the “Company”) is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary “Silence and Replace” DNA-directed RNA interference platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The Company is developing Silence and Replace-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). A comprehensive overview of the Company can be found on Benitec’s website at www.benitec.com.

Investor Relations Contact:

Irina Koffler
LifeSci Advisors
Tel: (917) 734-7387
ikoffler@lifesciadvisors.com


FAQ

What conferences will Benitec Biopharma (BNTC) attend in March 2025?

BNTC will attend TD Cowen Healthcare Conference (March 5), Leerink Partners Global Healthcare Conference (March 12), and the Muscular Dystrophy Association Conference (March 18-19) in Dallas.

What will BNTC present at the 2025 Muscular Dystrophy Association Conference?

BNTC will participate in sessions about Oculopharyngeal Muscular Dystrophy and present Clinical Trial Updates in Late-Breaking Oral Abstracts.

How can investors access Benitec's (BNTC) conference presentations in March 2025?

Investors can access BNTC's presentations via live webcasts for both the TD Cowen and Leerink Partners conferences.

What is Benitec Biopharma's (BNTC) main technology platform?

BNTC specializes in the 'Silence and Replace' DNA-directed RNA interference (ddRNAi) platform for developing novel genetic medicines.

When will BNTC present at the Leerink Partners Global Healthcare Conference 2025?

BNTC will present on March 12, 2025, from 9:20 AM to 9:50 AM EST in a Fireside Chat format.
Benitec Biopharm

NASDAQ:BNTC

BNTC Rankings

BNTC Latest News

BNTC Latest SEC Filings

BNTC Stock Data

449.01M
25.32M
3.12%
90.69%
5.05%
Biotechnology
Pharmaceutical Preparations
Link
United States
HAYWARD